COVID-19 Infection
📧 Sign up to get email alerts when something new happens for COVID-19 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: NCI COVID-19 in Cancer Patients, NCCAPS Study
A National Cancer Institute study (NCT04387656) evaluating COVID-19 infection in cancer patients is ongoing, with the trial status currently…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]
This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid rece…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
This MD Anderson-led clinical trial assesses how the COVID-19 pandemic has affected health-related quality of life in cancer patients and su…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: The Impact of COVID-19 on Pulmonary Procedures
A clinical trial update from MD Anderson Cancer Center notes that a study examining the impact of COVID-19 on pulmonary procedures is curren…
-
CLINICAL_TRIALS research · 2020-05-12Clinical Trial Update: COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) [Phase 2, Phase 3]
Clinical trial update for COVID-19 convalescent plasma in symptomatic COVID-19 patients (FALP-COVID), spanning Phase 2 and Phase 3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.